Lab Monthly Summary  
 
    Lab Name SRI BALAJI CLINICAL LABORATORY Lab No 6125  
    Month January Year 2020  
    Constituent Group Chemistry I      
Date of Result Entered : 15/01/2020
Date of Report Published : 11/02/2020
Sl.NoAnalyteMethod / Principle NameAnalyzer NameNo of ParticipantsDVParticipantsYour ValueSDIU
CVSD
1 GLUCOSE DRY CHEMISTRY JOHNSON & JOHNSON DRYCHEM SERIES233118.513.804.50117 mg/dl-0.340.59
2 UREA DRY CHEMISTRY JOHNSON & JOHNSON DRYCHEM SERIES24039.963.951.5839 mg/dl-0.610.20
3 CREATININE DRY CHEMISTRY JOHNSON & JOHNSON DRYCHEM SERIES2381.775.150.091.8 mg/dl0.330.01
4 T.BILIRUBIN DRY CHEMISTRY JOHNSON & JOHNSON DRYCHEM SERIES2391.4910.710.161.6 mg/dl0.690.02
5 T-PROTEIN DRY CHEMISTRY JOHNSON & JOHNSON DRYCHEM SERIES2334.983.900.195 g/dl0.100.03
6 ALBUMIN DRY CHEMISTRY JOHNSON & JOHNSON DRYCHEM SERIES2372.834.980.142.8 g/dl-0.210.02
7 CALCIUM DRY CHEMISTRY JOHNSON & JOHNSON DRYCHEM SERIES2318.223.920.328.4 mg/dl0.560.04
8 PHOSPHORUS DRY CHEMISTRY JOHNSON & JOHNSON DRYCHEM SERIES1984.575.620.264.6 mg/dl0.120.04
9 URIC ACID DRY CHEMISTRY JOHNSON & JOHNSON DRYCHEM SERIES2395.033.280.165 mg/dl-0.180.02
10 CHOLESTEROL DRY CHEMISTRY JOHNSON & JOHNSON DRYCHEM SERIES225105.454.684.94107 mg/dl0.310.66
11 TRIGLYCERIDE DRY CHEMISTRY JOHNSON & JOHNSON DRYCHEM SERIES222108.865.245.71110 mg/dl0.200.77
12 HDL CHO DRY CHEMISTRY JOHNSON & JOHNSON DRYCHEM SERIES21220.106.511.3119 mg/dl-0.840.18
13 SODIUM DRY CHEMISTRY JOHNSON & JOHNSON DRYCHEM SERIES183131.192.172.85131 mmol/L-0.070.42
14 POTASSIUM DRY CHEMISTRY JOHNSON & JOHNSON DRYCHEM SERIES1833.743.400.133.8 mmol/L0.470.02
15 CHLORIDE DRY CHEMISTRY JOHNSON & JOHNSON DRYCHEM SERIES14797.183.082.99103 mmol/L1.940.49
16 BICARBONATE DRY CHEMISTRY JOHNSON & JOHNSON DRYCHEM SERIES4619.058.581.6418 mmol/L-0.640.48
17 AST Dry Chemistry with PLP (P-5-P) JOHNSON & JOHNSON DRYCHEM SERIES21795.686.546.2696 U/L0.050.85
18 ALT Dry Chemistry with PLP (P-5-P) JOHNSON & JOHNSON DRYCHEM SERIES21031.489.983.1436 U/L1.440.43
19 ALP DRY CHEMISTRY JOHNSON & JOHNSON DRYCHEM SERIES23675.429.967.512.8 U/L-9.670.98
SDI RangeInterpretation
Within -1.0 to +1.0   Excellent.
Between ±1.0 to ±2.0   Good.
Between ±2.0 to ±3.0   Accept with caution. Warning Signal.
Beyond ±3.0   Unacceptable performance. Action Signal.
Page 1 of 1 
 
Homogeneity and Stability of the sample is passed.
 
         
  Dr. Pamela Christudoss
CMC EQAS Co-Ordinator
  Christian Medical College, Vellore
******* End of Report ******